Production
Pharma
Dispensaries
Investors
Sales and Operations
Consumer
Events and Networking
Politics and Law
Production
Pharma
Dispensaries
Investors
Sales and Operations
Consumer
Events and Networking
Politics and Law
Pharma
Marijuana Legalization Tied To ‘Significant Reductions’ In Prescription Drug Use, Researchers Find
Legalizing marijuana for adult use is associated with decreased use of prescription drugs for the treatment of conditions such as anxiety, sleep, pain, and seizures, according to a new research paper. Several previous studies have identified associations with the...
Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with “Project Change Lives”
For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their therapeutic and medicinal abilities. Scientists have identified at least 113 different chemicals in the plant — with tetrahydrocannabinol (THC) and cannabidiol (CBD) —...
Delta-8 marijuana products can be dangerous, health officials warn
U.S. health officials are warning about the potential dangers of "delta-8 THC," a compound derived from marijuana, after seeing an increase in hospitalizations tied to the substance. On Tuesday (Sept. 14), both the Centers for Disease Control and Prevention (CDC) and...
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
Combined sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex®, Dronabinol, and Sativex® – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, released today by global cannabis...
JAMA Study Finds “Little Evidence” of Link Between Cannabis Legalization and Youth Use
A new, updated study published Monday in the JAMA Network Open found “little evidence” that adult and medical use cannabis legalization “encourage youth marijuana use.” The study, conducted by researchers from the Department of Agricultural Economics at Montana State...
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
Combined sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol, and Sativex – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, from global cannabis industry...
South Africa’s 1st cannabis business plots course for IPO within year
Cilo Cybin Pharmaceutical Ltd. is considering an initial public offering in the next 12 months after becoming the first South African company to win the right to grow, process, and package cannabis products. The firm, named after the psychoactive substance in magic...
Indica News
(833) 769-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Quicklinks
Follow Us
Indica News
(833) 450-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM
Follow Us
Quicklinks
Indica News
(833) 450-9333
info@indica.news
Monday - Friday: 8:00 AM - 5:00 PM